510 Baseline characteristics, hemodynamic, clinical and biochemical response to candesartan in a prospective, multicenter pharmacogenomic study of heart failure patients already receiving an ace inhibitor

2011 ◽  
Vol 27 (5) ◽  
pp. S247-S248
Author(s):  
S. de Denus ◽  
M.S. Phillps ◽  
M. Dubé ◽  
J. Turgeon ◽  
J. Lavoie ◽  
...  
Keyword(s):  
Heart Failure ◽  
Ace Inhibitor ◽  
Biochemical Response ◽  
Heart Failure Patients ◽  
Baseline Characteristics

scholarly journals Cost Analysis of Combination Diuretic Therapy with Ace-Inhibitors to Diuretic Therapy without Ace-Inhibitors in Heart Failure Patients

2016 ◽  
Vol 15 (3) ◽  
pp. 368-375
Author(s):  
Fajar Wahyu Pribadi ◽  
Iwan Dwiprahasto ◽  
Jarir At Thobari
Keyword(s):  
Heart Failure ◽  
Combination Therapy ◽  
Cost Analysis ◽  
Ace Inhibitors ◽  
Ace Inhibitor ◽  
Diuretic Therapy ◽  
Medical Science ◽  
High Morbidity ◽  
Major Health Problem ◽  
Heart Failure Patients

Background: Heart failure is the final stage of the entire heart disease and become a major health problem because of the high morbidity and mortality. Diuretic combination therapy with ACE inhibitors compared to diuretic therapy without ACE inhibitors will affect the costs and hospitalization for heart failure patients; so it can be used to study Pharmacoeconomics.Method and Design: This study is an analytic observational retrospective cohort study design. Researchers compared the cost analysis between groups having diuretic combination therapy with an ACE inhibitor and diuretic therapy without ACE inhibitors. Data taken with a total sampling of heart failure databases claimed prescribing health insurance PT. ASKES Persero between January 1, 2010 until December 31, 2011.Results: Out of the 377 patients of the study population, 64 patients received combination therapy with ACE inhibitors and diuretics, and 60 patients received diuretic therapy without ACE inhibitors. The analysis showed that the total cost was Rp. 4.96 million and Rp. 5.14 million; the average total inpatient days a year was 10.67 days and 7.00 days.Conclusion: This study showed that the diuretic combination therapy with an ACE inhibitor is more cost-effective. Further research is needed to assess the total costs and effectiveness of therapy with more number of subjects and longer periods.Bangladesh Journal of Medical Science Vol.15(3) 2016 p.368-375

Consistent survival benefit of carvedilol over metoprolol irrespective of baseline characteristics of heart failure patients – mode of death evaluation in COMET

2004 ◽  
Vol 10 (4) ◽  
pp. S84 ◽  
Author(s):  
Willem J. Remme ◽  
John G. Cleland ◽  
Andrea Di Lenarda ◽  
Christian Torp-Pederson ◽  
Marco Metra ◽  
...  
Keyword(s):  
Heart Failure ◽  
Survival Benefit ◽  
Heart Failure Patients ◽  
Baseline Characteristics ◽  
Mode Of Death
Sign in / Sign up

Export Citation Format

Share Document